AS2553627
AS2553627 is a type of JAK inhibitor, with IC50 values of 0.46, 0.30, 0.14, and 2.0 nM for JAK1, JAK2, JAK3 and TYK2, respectively. AS2553627 can inhibit the proliferation of human and rat T cells stimulated by IL-2, with IC50 values of 2.4 and 4.3 nM, respectively. AS2553627 can reduce cardiac allograft vasculopathy and fibrosis in a rat heart transplant model, effectively extending survival rates. AS2553627 can be used to prevent acute and chronic rejection in heart transplants[1].
Product Specifications
CAS Number
1251906-10-1
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/as2553627.html
Smiles
N#CCC(N1C[C@H](N2C=CC3=CN=C(NC=C4)C4=C32)[C@H](C)CC1)=O
Molecular Formula
C18H19N5O
Molecular Weight
321.38
References & Citations
[1]Nakamura K, et al. AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. Eur J Pharmacol. 2017 Feb 5;796:69-75.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK1; JAK2; JAK3; Tyk2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Renal Cell Carcinoma (Carbonic Anhydrase IX) (CA9/2993R), Biotin conjugate, 0.1mg/mL
MAGOHP sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Glucose Transporter 14 (GLUT14), Recombinant, Human
Glucose Transporter 14 (GLUT14), Recombinant, Human
Glucose Transporter 14 (GLUT14), Recombinant, Human
